Climb Bio, Inc. SEC filings CLYM
Climb Bio, Inc. has 325 filings in SEC EDGAR's recent list, going back to Feb 19, 2019. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 9, 2026 | — |
| CORRESP | Letter to the SEC | Jun 5, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2026 | — |
| D | Filing | May 4, 2026 | — |
| EFFECT | Filing | Nov 22, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2024 | — |
| EFFECT | Filing | Jul 23, 2024 | — |
| CORRESP | Letter to the SEC | Jul 19, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2024 | — |
| D | Filing | Jul 2, 2024 | — |
| D | Filing | Jul 2, 2024 | — |
| EFFECT | Filing | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 9, 2021 | — |
| CERT | Filing | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 4, 2021 | — |
| CORRESP | Letter to the SEC | Aug 4, 2021 | — |
| CORRESP | Letter to the SEC | Aug 3, 2021 | — |
| 8-A12B | Filing | Aug 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 2, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| DRSLTR | Filing | Jul 12, 2021 | — |
| DRS/A | Filing | Jul 12, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| DRSLTR | Filing | Jun 21, 2021 | — |
| DRS/A | Filing | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2021 | — |
| D | Filing | May 28, 2021 | — |
| DRS | Filing | May 12, 2021 | — |
| D | Filing | Nov 3, 2020 | — |
| D | Filing | Oct 23, 2019 | — |
| D/A | Filing | Oct 23, 2019 | — |
| D | Filing | Feb 19, 2019 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLYM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wellesley Hills, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1768446
- Former names
- Eliem Therapeutics, Inc. (until Sep 20, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.